144 results on '"de‐Torres, Juan P."'
Search Results
2. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma
3. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience
4. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease
5. Late Breaking Abstract - Systemic Determinants of Exercise Intolerance in Patients with Fibrosing Interstitial Lung Disease and a Severely Impaired DLCO
6. Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired DLCO
7. “Another Hole in the Wall”
8. Physiological underpinnings of exertional dyspnoea in mild fibrosing interstitial lung disease
9. Neurophysiological Mechanisms of Exertional Dyspnea in Post-Pulmonary Embolism Syndrome
10. COPD detection in lung cancer screening programmes: “hitting two birds with one stone”
11. Continuous Monitoring of Pulse Oximetry During the 6-Minute Walk Test Improves Clinical Outcomes Prediction in COPD
12. Ventilatory neural drive in chronically hypercapnic patients with COPD: effects of sleep and nocturnal noninvasive ventilation
13. Inhaled corticosteroids, COPD, and the incidence of lung cancer: a systematic review and dose response meta-analysis
14. Impaired Ventilatory Efficiency, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease: Results from the CanCOLD Study
15. New or enlarging hiatal hernias after thoracic surgery for early lung cancer
16. Severe exacerbations and mortality in COPD: Importance of both body and mind
17. Lung Cancer Screening in Patients With Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Risks?
18. Lung Cancer Risk among Patients with Asthma–Chronic Obstructive Pulmonary Disease Overlap
19. Lung Cancer Screening in Patients With Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Risks?
20. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD
21. Mechanisms of Exertional Dyspnea in Patients with Mild COPD and a Low Resting DLCO
22. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD
23. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD
24. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
25. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
26. Qualitative Components of Dyspnea during Incremental Exercise across the COPD Continuum
27. Recent Advances in the Physiological Assessment of Dyspneic Patients with Mild COPD
28. Nocturnal Hypoxemia and CT Determined Pulmonary Artery Enlargement in Smokers
29. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort
30. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort
31. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data
32. Sex differences in COPD outcome in 5,355 women with COPD: A new analysis of the 3CIA study
33. Lung Function Testing in Chronic Obstructive Pulmonary Disease
34. Exercise Tolerance according to the Definition of Airflow Obstruction in Smokers
35. Sex differences between women and men with COPD: A new analysis of the 3CIA study
36. Exploring the Association Between Emphysema Phenotypes and Low Bone Mineral Density in Smokers with and without COPD
37. Somatotypes trajectories during adulthood and their association with COPD phenotypes
38. A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
39. Prevalence and burden of bronchiectasis in a lung cancer screening program
40. Somatotypes trajectories during adulthood and its association with Chronic Obstructive Pulmonary Disease (COPD) phenotypes
41. B Cell–Adaptive Immune Profile in Emphysema-Predominant Chronic Obstructive Pulmonary Disease
42. Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial
43. Prognostic Validation Using GesEPOC 2017 Severity Criteria
44. Validación pronóstica según los criterios de la GesEPOC 2017
45. Emphysema phenotypes and lung cancer risk
46. The Prevalence of Obstructive Lung Disease in a Lung Cancer Screening Cohort: Analysis of the National Lung Screening Trial–American College of Radiology Image Network Cohort
47. Survival with Parenchymal and Pleural Invasion of Non–Small Cell Lung Cancers Less than 30 mm
48. Trabecular bone score in active or former smokers with and without COPD
49. The Global Burden of Pulmonary Diseases: Most Prevalent Problems and Opportunities for Improvement
50. 5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.